{
    "2018-11-19": [
        [
            {
                "time": "",
                "original_text": "蔚蓝生物关联方引监管问询 实控人曾是新希望高管",
                "features": {
                    "keywords": [
                        "蔚蓝生物",
                        "关联方",
                        "监管问询",
                        "实控人",
                        "新希望",
                        "高管"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技",
                        "农业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "陈春花：患上这两个毛病的公司，未来是没有希望的",
                "features": {
                    "keywords": [
                        "陈春花",
                        "公司问题",
                        "未来发展",
                        "管理问题"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}